Results 71 to 80 of about 6,879 (203)

Combining rimonabant and fentanyl in a single entity: Preparation and pharmacological results [PDF]

open access: yes, 2014
Based on numerous pharmacological studies that have revealed an interaction between cannabinoid and opioid systems at the molecular, neurochemical, and behavioral levels, a new series of hybrid molecules has been prepared by coupling the molecular ...
Erdozain, Amaia M   +23 more
core   +1 more source

A consensus roadmap for post‐traumatic epilepsy: Clinical biomarkers, research priorities, policy barriers, and pathways to interventional trials

open access: yesEpilepsia, Volume 67, Issue 7, Page 3281-3299, July 2026.
Abstract Understanding the mechanisms underlying post‐traumatic epilepsy (PTE) following traumatic brain injury (TBI), and developing strategies to prevent or modify its progression, has been the focus of large collaborative efforts within the epilepsy and TBI research communities for over a decade.
Elisa R. Zanier   +82 more
wiley   +1 more source

The role of exercise training and the endocannabinoid system in atherosclerotic plaque burden and composition in Apo-E-deficient mice

open access: yesHellenic Journal of Cardiology, 2016
Introduction: We investigated the effect of combining exercise training and treatment with an endocannabinoid receptor 1 inhibitor (Rimonabant) on atherosclerosis burden and composition. Methods: Forty-eight apolipoprotein E-deficient (ApoE-/-) mice were
Michalis Katsimpoulas   +8 more
doaj   +1 more source

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 14, Page 3970-3991, July 2026.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander   +5 more
wiley   +1 more source

Microbiome‐Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease [PDF]

open access: yesFASEB Bioadv
The microbiome‐eCBome axis is operationalized across five measurable domains: microbial functions, compartment‐specific lipid signaling, barrier/translocation, immune‐cell programming, and tissue outcomes. Engineered PEA‐ and OEA‐producing bacteria provide causal proof‐of‐concept, while translation requires tissue‐resolved lipidomics, validated barrier
Maghembe R   +3 more
europepmc   +2 more sources

Effectiveness of Alcohol Use Disorder Pharmacotherapies by Sex: Systematic Review and Meta‐Analysis

open access: yesDrug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Issues Alcohol use disorder (AUD) shows sex‐related differences in prevalence, harm and treatment response. Despite growing interest in sex differences, evidence synthesis evaluating pharmacotherapy effectiveness by sex remains limited. Approach Web of Science, PubMed, Scopus, PsycINFO and Cochrane were searched twice.
Juliette Allen   +11 more
wiley   +1 more source

Rimonabant inhibits TNF- -induced endothelial IL-6 secretion via CB1 receptor and cAMP-dependent protein kinase pathway=NA

open access: yes, 2011
Aim: To investigate whether rimonabant, a cannabinoid receptor antagonist , had inhibitory effects on inflammatory reactions in human umbilical vein endothelial cells (HUVEC).
黃南嵐;莊志明;林俊立;蔡佳醍;賴凌平   +1 more
core  

1,1‐Disubstituted Vinylbromides: Versatile Building Blocks for the Synthesis of Nitrogen‐Containing Heterocycles

open access: yesEuropean Journal of Organic Chemistry, Volume 29, Issue 23, 16 June 2026.
1,1‐Disubstituted vinylbromides are key intermediates for constructing nitrogen‐containing heterocycles. This review provides an overview of the synthetic applications of 1,1‐disubstituted vinylbromides and summarizes recent developments in reaction methodologies, mechanistic insights, and the structural diversity of N‐heterocyclic compounds accessible
Anne Westermeyer   +6 more
wiley   +1 more source

Rimonabant Inhibits Tnf-Alpha-Induced Endothelial Il-6 Secretion Via Cb1 Receptor and Camp-Dependent Protein Kinase Pathway

open access: yes, 2011
Aim: To investigate whether rimonabant, a cannabinoid receptor antagonist , had inhibitory effects on inflammatory reactions in human umbilical vein endothelial cells (HUVEC).
黃南嵐;莊志明;王怡和;薛嘉祥;梁耀仁;林俊立;蔡佳醍;賴凌平   +1 more
core  

Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats

open access: yes, 2006
Rationale: Previous work indicated that tolerance to the anorectic effect of the cannabinoid CB1 receptor antagonist/inverse agonist, rimonabant, developed rather rapidly in rats and mice given access to a standard rodent chow.
Lobina C   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy